Table 1 Number of serum samples with antibody-dependent enhancement (ADE) activitya to each of the 4 dengue virus (DENV) serotypes, pre- and post-Japanese encephalitis (JE) vaccination
From: Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults
Samples | Number of serum samples that demonstrated ADE activity (Percentage of samples with ADE activity) | |||
|---|---|---|---|---|
DENV-1 | DENV-2 | DENV-3 | DENV-4 | |
Pre-JE vaccination (n = 77) | 5 (6 %) | 2 (3 %) | 11 (14 %) | 10 (13 %) |
Post-JE vaccination (n = 77) | 14 (18 %) | 16 (21 %) | 24 (31 %) | 24 (31 %) |